Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1115P is a human pseudogene related to U6 small nuclear RNA, which is normally an essential non-coding RNA component of the spliceosome involved in pre-mRNA splicing[1][2][3][4]. Pseudogenes are non-functional copies or remnants of functional genes and generally have no protein or RNA product with biological activity[3]. The RNU6-1115P pseudogene is not known to produce a functional RNA or protein and has no established role in cellular function or disease. U6 pseudogenes such as RNU6-1115P are common in the human genome[1][3]. There is no evidence that this pseudogene acts as a therapeutic target, biomarker, or has direct interaction with any drugs or established disease relevance. Its identification mainly reflects genomic duplication or retrotransposition events that occurred during evolution[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1115, pseudogene (RNU6-1115P).